Dimension Research
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
CTRL + ALT + DEPLETE
Resetting a dysfunctional immune system via the selective depletion of rogue cells is an emerging therapeutic strategy, having matured in the oncology…
Feb 24
•
Dimension
8
Share this post
Dimension Research
CTRL + ALT + DEPLETE
Copy link
Facebook
Email
Notes
More
December 2024
NeurIPS 2024 Open Notes
Our team visited Vancouver to attend NeurIPS 2024. These are our initial notes from many of the AI x Biology workshops.
Dec 22, 2024
•
Dimension
8
Share this post
Dimension Research
NeurIPS 2024 Open Notes
Copy link
Facebook
Email
Notes
More
MoML 2024 Open Notes
Our team recently attended the MoML Conference in Boston. We've curated a selection of our notes to push out into the open. Enjoy!
Dec 14, 2024
•
Dimension
7
Share this post
Dimension Research
MoML 2024 Open Notes
Copy link
Facebook
Email
Notes
More
2
October 2024
RMC-6236: A Curious Macrocycle
Macrocycles are a potent, intriguing class of therapies that are growing in importance. Revolution Medicines' RMC-6236 is a perfect example.
Oct 11, 2024
•
Dimension
7
Share this post
Dimension Research
RMC-6236: A Curious Macrocycle
Copy link
Facebook
Email
Notes
More
1
September 2024
Cryptic Pockets: 'X' Marks the Spot
Cryptic binding pockets are like buried treasure. They're mysterious, difficult to find, and come with untold riches once surfaced.
Sep 13, 2024
•
Dimension
4
Share this post
Dimension Research
Cryptic Pockets: 'X' Marks the Spot
Copy link
Facebook
Email
Notes
More
2
Unnatural Amino Acids
The extended amino acid alphabet is full of strangeness, but may hold the key to breakthrough applications in the life sciences.
Sep 5, 2024
•
Dimension
14
Share this post
Dimension Research
Unnatural Amino Acids
Copy link
Facebook
Email
Notes
More
3
July 2024
Long Live Radiopharmaceuticals!
Radiotherapy is an oncological mainstay. Targeted radiopharmaceuticals are sweeping the clinical landscape, but face substantial hurdles to realize…
Jul 31, 2024
•
Dimension
2
Share this post
Dimension Research
Long Live Radiopharmaceuticals!
Copy link
Facebook
Email
Notes
More
June 2024
An Opinionated AlphaFold3 Field Guide
I break down every part of AlphaFold3 in simple-to-understand terms and give my observations and opinions along the way.
Jun 12, 2024
•
Dimension
20
Share this post
Dimension Research
An Opinionated AlphaFold3 Field Guide
Copy link
Facebook
Email
Notes
More
1
May 2024
Receptors Unite: Agonism with Antibodies
Virtually all FDA-approved antibodies neutralize block cell surface receptors. Why is building an activating (agonizing) antibody interesting? Why has…
May 6, 2024
•
Dimension
3
Share this post
Dimension Research
Receptors Unite: Agonism with Antibodies
Copy link
Facebook
Email
Notes
More
April 2024
Weekend ADC Musings
Antibody-drug conjugates (ADCs) are here to stay. But how much agreement is there as to how they work, why they're more effective, and why they're more…
Apr 21, 2024
•
Dimension
4
Share this post
Dimension Research
Weekend ADC Musings
Copy link
Facebook
Email
Notes
More
February 2024
NeurIPS 2023 Roundup: Drug-Target Interaction (DTI) Prediction
Data on drugs, drug targets, genetic regulatory networks, phenotypes, pathways, and more are proliferating. Pooling everything together to power DTI…
Feb 12, 2024
•
Dimension
2
Share this post
Dimension Research
NeurIPS 2023 Roundup: Drug-Target Interaction (DTI) Prediction
Copy link
Facebook
Email
Notes
More
January 2024
NeurIPS 2023 Roundup: Generative Molecular Design
Similar to therapeutic proteins, NeurIPS 2023 was packed with engaged discussions around the opportunities (and pitfalls!) of generative chemistry…
Jan 25, 2024
•
Dimension
4
Share this post
Dimension Research
NeurIPS 2023 Roundup: Generative Molecular Design
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
